. Author manuscript; available in PMC: 2019 Jun 3.

Published in final edited form as: Eur J Cancer. 2010 Mar 20;46(7):1177–1180. doi: 10.1016/j.ejca.2010.02.039

Table 1 –

Examples of funding for metastasis research as a percentage of total cancer research funding.

Organisation/country	Period	Cancer research funding	Metastasis research^*	% Devoted to metastasis
Deutsche Krebshilfe (German Cancer Aid)^a	2007	73,150,000 EUR	3,191,000 EUR	4.3
National Cancer Research Institute Partners, UK^b	2002	£ 257,000,000	£ 74,000,000	2.9
National Cancer Research Institute Partners, UK^b	2006	£ 391,000,000	£ 200,000,000	5.1
Oncosuisse, Swiss Cancer League and Foundation	2006–2008	43,943,750 CHF	5,094,400 CHF	11.6
Cancer Research, Switzerland^c
European Union (FP6)^d	2002–2006	485,000,000 EUR	24,205,137 EUR	5,0
American Cancer Society, USA^e	2009	485,000,000 $	11,000,000 $	2.3
Canadian Cancer Research, Alliance^f	2006	390,200,000 CAD	25,200,000 CAD	6.5

Keywords: Metastasis; Dissemination; Invasion; Progression.

Deutsche Krebshilfe Annual Report 2008, <http://www.krebshilfe.de/ueber-uns0.html>.

NCRI web site: <http://www.ncri.org.uk/default.asp?s=1&p=3&ss=2>.

‘Cancer Research in Switzerland, a Publication of Oncosuisse, Swiss Cancer League and Foundation Cancer Research, Switzerland on their funded research projects 2006–2008’ Edition 2009; <http://www.swisscancer.ch/research>.

Jungbluth S, Kelm O, van de Loo JW, Manoussaki E, Vidal M, Hallen M, Trias OQ. Mol Oncol 2007;1:14–18. <http://www.lifecompetence.eu/index.php/kb_317/kb.html>.

ACS website: <http://www.cancer.org/docroot/RES/RES_3.asp?sitearea=RES&level=1>.

Cancer Research Investment in Canada 2006, report published by CCRA (http://www.ccra-acrc.ca/default_en.htm).